Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Dow
US Army
Healthtrust
Covington
Queensland Health
Daiichi Sankyo
Accenture
Express Scripts
Medtronic

Generated: October 18, 2017

DrugPatentWatch Database Preview

ATOMOXETINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

Which patents cover Atomoxetine Hydrochloride, and when can generic versions of Atomoxetine Hydrochloride launch?

Atomoxetine Hydrochloride is a drug marketed by Aurobindo Pharma Ltd, Zydus Pharms Usa Inc, Glenmark Pharms Ltd, Teva Pharms Usa, and Apotex Inc. and is included in five NDAs.

The generic ingredient in ATOMOXETINE HYDROCHLORIDE is atomoxetine hydrochloride. There are fourteen drug master file entries for this compound. Thirteen suppliers are listed for this compound. There are seven tentative approvals for this compound. Additional details are available on the atomoxetine hydrochloride profile page.

Summary for Tradename: ATOMOXETINE HYDROCHLORIDE

US Patents:0
Applicants:5
NDAs:5
Suppliers / Packagers: see list5
Bulk Api Vendors: see list42
Clinical Trials: see list2,384
Patent Applications: see list1,102
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ATOMOXETINE HYDROCHLORIDE at DailyMed

Pharmacology for Tradename: ATOMOXETINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apotex Inc
ATOMOXETINE HYDROCHLORIDE
atomoxetine hydrochloride
CAPSULE;ORAL078983-005May 30, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Apotex Inc
ATOMOXETINE HYDROCHLORIDE
atomoxetine hydrochloride
CAPSULE;ORAL078983-001May 30, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Apotex Inc
ATOMOXETINE HYDROCHLORIDE
atomoxetine hydrochloride
CAPSULE;ORAL078983-006May 30, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Apotex Inc
ATOMOXETINE HYDROCHLORIDE
atomoxetine hydrochloride
CAPSULE;ORAL078983-002May 30, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Aurobindo Pharma Ltd
ATOMOXETINE HYDROCHLORIDE
atomoxetine hydrochloride
CAPSULE;ORAL079016-001May 30, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Glenmark Pharms Ltd
ATOMOXETINE HYDROCHLORIDE
atomoxetine hydrochloride
CAPSULE;ORAL079019-005May 30, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Teva Pharms Usa
ATOMOXETINE HYDROCHLORIDE
atomoxetine hydrochloride
CAPSULE;ORAL079022-004May 30, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Aurobindo Pharma Ltd
ATOMOXETINE HYDROCHLORIDE
atomoxetine hydrochloride
CAPSULE;ORAL079016-007May 30, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Aurobindo Pharma Ltd
ATOMOXETINE HYDROCHLORIDE
atomoxetine hydrochloride
CAPSULE;ORAL079016-004May 30, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Zydus Pharms Usa Inc
ATOMOXETINE HYDROCHLORIDE
atomoxetine hydrochloride
CAPSULE;ORAL079017-005Sep 17, 2010DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Colorcon
McKinsey
Julphar
Chinese Patent Office
Medtronic
Express Scripts
Novartis
Harvard Business School
US Department of Justice
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot